Trial Profile
A phase II study of the safety and efficacy of adding entecavir to current lamivudine therapy in HIV and HBV [hepatitis B virus] co-infected patients who have hepatitis B viremia while being treated with lamivudine
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 27 Apr 2011
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine
- Indications Hepatitis B; HIV infections
- Focus Therapeutic Use
- 22 Oct 2005 New trial record.